9. When deciding on the price to charge for lifesaving drugs, should executives of pharmaceutical companies follow Milton Friedman's advice to "make as much money as possible for stockholders"? What might Friedman say about Merck's Mectizan program and Johnson & Johnson's Tylenol® decision?